BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 21, 2006
View Archived Issues
DHEA beneficial for long-term morphine use
Read More
Ralfinamide blocks chronic pain behavior and underlying neural ectopic activity
Read More
Snapshots on antidiabetic drug candidates in clinical development
Read More
Polyphenolic extract from red grapes beneficial for metabolic syndrome
Read More
Nymox reports promising phase II with NX-1207 for BPH
Read More
NovaCal and Alcon enter licensing agreement for nonantibiotic antiinfective compounds
Read More
Preclinical studies of Novavax intranasal flu vaccines begin
Read More
Wyeth presents novel Kv channel disinactivator, with efficacy in a seizure model
Read More
ABT-888: A PARP inhibitor in a phase 0 trial at NCI
Read More
Merck & Co. reveals new Chk1 inhibitors
Read More
Schering-Plough presents new lead BACE1 inhibitor
Read More
Pepscan equity investment supports progress in R&D pipeline
Read More
AnorMED broadens scope of Poniard's picoplatin license
Read More
Pharmacopeia advances Organon's lead compounds
Read More
Rigel receives milestone payment from Serono
Read More
Nastech's intranasal insulin begins phase I clinical evaluation
Read More
Early clinical trials begin with sanofi-pasteur's H7N1 pandemic vaccine
Read More
Seaside Therapeutics awarded Autism Speaks grant
Read More
pSivida initiates phase II trial of mifepristone eye drops for IOP
Read More
Frova for menstrual migraine prevention accepted for filing in U.S.
Read More
Alexion seeks U.S. approval for treatment of rare genetic blood disorder
Read More
Idenix receives first approval for novel CHB treatment
Read More
Recent patents describe new treatment options for endocrine-related disorders
Read More
New agents for treating blood coagulation disorders reported in recent patents
Read More
Recent patents disclose novel treatment strategies for HCV infection
Read More
Novel long-acting form of BNP shows potential for cardiovascular and renal disorders
Read More
Novel leukotriene A4 hydrolase inhibitors reported by deCODE
Read More
New CCR5 antagonists to treat HIV infection prepared and tested at GSK
Read More
